115 studies found for:    "Choreatic Disorders" OR "McLeod neuroacanthocytosis syndrome" OR "Neuroacanthocytosis" OR "Chorea Acanthocytosis Syndromes"
Show Display Options
Rank Status Study
21 Recruiting Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: PF-02545920;   Other: Placebo
22 Completed Escalating Dose Study in Healthy Volunteers With SEN0014196
Condition: Huntington's Disease
Intervention: Drug: SEN0014196
23 Completed Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: PF-02545920;   Drug: Placebo
24 Completed Memory Disorders Registry
Conditions: Dementia;   Alzheimer's Disease;   Parkinson Disease;   Huntington Disease
Intervention:
25 Completed Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability
Condition: Huntington's Disease
Intervention: Drug: Creatine monohydrate
26 Completed A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers
Conditions: Alzheimer's Disease;   Huntington's Disease
Interventions: Drug: Dimebon alone;   Drug: Dimebon + Ketoconazole;   Drug: Dimebon + Omeprazole
27 Not yet recruiting ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders
Conditions: Movement Disorders;   Essential Tremor;   Holmes Tremor;   Parkinson's Disease;   Wilson's Disease;   Huntington's Disease;   Dystonia;   Tardive Dyskinesia;   Orofacial Dyskinesias
Intervention: Device: Transcranial ExAblate System
28 Recruiting Study Exploring Safety, Pharmacokinetic and Pharmacodynamic of BN82451 in Male Huntington's Disease Patients
Condition: Huntington's Disease
Interventions: Drug: BN82451B;   Drug: Placebo
29 Completed
Has Results
Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease
Condition: Huntington's Disease
Intervention:
30 Recruiting Cooperative Huntington's Observational Research Trial
Condition: Huntington Disease
Intervention:
31 Completed Creatine Safety and Tolerability in Premanifest HD: PRECREST
Condition: Huntington Disease
Interventions: Drug: Creatine monohydrate;   Drug: Placebo
32 Completed Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease
Condition: Huntington Disease
Intervention: Drug: triheptanoin oil
33 Recruiting Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)
Condition: Huntington Disease
Intervention:
34 Not yet recruiting Resveratrol and Huntington Disease
Condition: Huntington Disease
Interventions: Dietary Supplement: Resveratrol;   Other: Placebo
35 Completed A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function
Conditions: Alzheimer's Disease;   Huntington's Disease
Intervention: Drug: Dimebon
36 Completed Research of Biomarkers in Parkinson Disease
Conditions: Parkinson Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy;   Huntington Disease;   Dystonia;   Diffuse Lewy Body Disease
Intervention:
37 Recruiting Brain Structure and Function in Children at Risk for Huntington's Disease
Condition: Huntington's Disease
Intervention:
38 Completed Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
Condition: Huntington's Disease
Intervention: Drug: Dimebon
39 Completed A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease
Condition: Huntington Disease
Interventions: Drug: Memantine;   Other: Placebo
40 Recruiting A Biospecimen and Clinical Data Study on Patients With Alzheimer's, Multiple Sclerosis, Parkinson's, and Huntington's, for Drug & Biomarker Discovery
Conditions: Alzheimer's Disease;   Multiple Sclerosis;   Parkinson's Disease;   Huntington's Disease;   Amyotrophic Lateral Sclerosis (ALS)
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years